Organism: Homo sapiens
Gene: O95377
Selected probe(set): 206156_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of O95377 (206156_at) across 5610 perturbations tested by GENEVESTIGATOR:

Relative Expression (log2-ratio):-3.8827362
Number of Samples:20 / 18

Experimental	esophageal adenocarcinoma study 1
	Esophageal adenocarcinoma (EAC) samples of affected epithelium recovered by laser capture microdissection technique.
Control	normal esophageal epithelium sample
	Histologically normal esophageal squamous cell epithelium biopsy samples from patients that were investigated for esophageal pain, but diagnosed as healthy.

Relative Expression (log2-ratio):-3.3384447
Number of Samples:17 / 18

Experimental	Barrett's esophagus study 3
	Esophageal epithelium samples from areas with Barrett's esophagus metaplasia which were recovered by laser capture microdissection.
Control	normal esophageal epithelium sample
	Histologically normal esophageal squamous cell epithelium biopsy samples from patients that were investigated for esophageal pain, but diagnosed as healthy.

Relative Expression (log2-ratio):-3.2240973
Number of Samples:38 / 4

Experimental	Merkel cell carcinoma study 3 (primary)
	Primary tumor tissue from the skin of patients with Merkel cell carcinoma.
Control	skin squamous cell carcinoma study 6
	Primary tumor tissue from the skin of patients with squamous cell carcinoma (SCC).

Relative Expression (log2-ratio):-3.0688362
Number of Samples:38 / 64

Experimental	Merkel cell carcinoma study 3 (primary)
	Primary tumor tissue from the skin of patients with Merkel cell carcinoma.
Control	normal skin tissue
	Normal skin samples from healthy donors.

Relative Expression (log2-ratio):-3.0341473
Number of Samples:22 / 64

Experimental	Merkel cell carcinoma study 3 (metastatic)
	Metastatic tumor tissue from different metastatic sites (skin, lymph node, parotid gland) of patients with Merkel cell carcinoma of the skin.
Control	normal skin tissue
	Normal skin samples from healthy donors.

Relative Expression (log2-ratio):2.753337
Number of Samples:31 / 44

Experimental	lung squamous cell carcinoma study 1
	Primary lung squamous cell carcinoma samples of a patient with non-small cell lung cancer.
Control	normal lung tissue
	Histologically normal lung tissue.

Relative Expression (log2-ratio):2.426978
Number of Samples:27 / 65

Experimental	non-small cell lung cancer study 8 (squamous cell carcinoma)
	Primary tumor tissue sample obtained from the lung of patients squamous cell carcinoma.
Control	adjacent lung tissue
	Histological normal lung tissue samples from patients with lung cancer.

Relative Expression (log2-ratio):2.2847404
Number of Samples:27 / 18

Experimental	non-small cell lung cancer study 8 (squamous cell carcinoma)
	Primary tumor tissue sample obtained from the lung of patients squamous cell carcinoma.
Control	non-small cell lung cancer study 8 (large cell carcinoma)
	Primary tumor tissue sample obtained from the lung of patients large cell carcinoma.

Relative Expression (log2-ratio):2.1569777
Number of Samples:20 / 19

Experimental	atopic dermatitis study 12 (non-lesional; adults)
	Unaffected skin biopsy samples from adult patients (age range 18-73 years) with long-standing atopic dermatitis.
Control	atopic dermatitis study 12 (non-lesional; children)
	Unaffected buttock skin biopsy samples from pediatric patients (age range 3 months-5 years) with early-onset atopic dermatitis. All patients had moderate-to-severe disease (SCORAD score: mean, 57.8; range, 33-84) with recent-onset (within the previous 6 months). Systemic immunosuppressants within the past 4 weeks, topical steroids or immunomodulators within 1 week, or moisturizers within 12 hours before evaluation were restricted. Patients with active skin infections were excluded.

Relative Expression (log2-ratio):-2.1273184
Number of Samples:3 / 3

Experimental	gefitinib study 2
	Gefitinib-resistant A431 (A431 GR) cells generated by growing parental cells in the presence of increasing concentrations of gefitinib up to 3 μM. Cells were selected and maintained in gefitinib (3μM). ATC code:
Control	wild type A431 cell sample
	A431 wild type cells.